MUJHU Research Collaboration

Vaccines in Pregnancy and Infancy: National Stakeholders Meeting
2023-05-12 07:45 - 13:00 UTC
The Makerere University-Johns University Research Collaboration (MU-JHU) in partnership with St Georges University London (SGUL) is inviting you to a special stakeholder meeting to discuss current study findings and future vaccine research in pregnant women and infants in Uganda.
The investigators will present updates on current studies within the portfolio and proposed vaccine and observational studies. You will be given an opportunity to ask questions and discuss issues related to vaccination in pregnancy and infancy.
Several studies have been underway with your support since 2018 to set the scene for maternal and infant vaccine clinical trials in Uganda. These include:

The PROGRESS study, to determine the incidence of Group B Streptococcal disease (GBS), colonization and neurodevelopmental impairment following infant disease. This study also includes a comprehensive overview of other pathogens that cause disease in the first months of life for which vaccines are or will soon be available to be given to pregnant women or their infants. This study will complete follow up in September 2023.
The WOMANPOWER study, to determine the safety and efficacy of a pertussis-containing vaccine (TDaP) given to pregnant women living with HIV. This study has completed and interim results are available.
The PREPARE studies: This includes the development of a pregnancy exposures registry and background rates of adverse events in sentinel sites that has also been used to monitor adverse events in pregnancy and infancy during the COVID-19 pandemic (periCOVID study). Pfizer Multivalent CPS-conjugate vaccine trial in pregnant HIV-infected and uninfected women investigating the safety and immunogenicity of the vaccine in pregnant women and the subsequent transfer of vaccine induced antibodies to their infants. Minervax GBS vaccine trial in pregnant HIV-infected and uninfected women investigating the safety and immunogenicity of the vaccine in pregnant women and the subsequent transfer of vaccine induced antibodies to their infants. This programme of work also includes a large component of vaccine hesitancy work. Updates will be presented on progress to date.

We will also take the opportunity to update you on upcoming studies within the portfolio and seek your input. These include:

Measles remains a common cause of morbidity and mortality in infants under five years worldwide, with occurrence substantially noted in regions with low vaccination rates. While it is generally believed infants are protected by maternal antibodies for 6-9 months, an over representation of infants under 6 months has been shown in recent outbreaks. Vaccination of infants earlier than the standard 9months with a booster dose may confer protection to these children earlier.BoostME trial: Earlier prime-boost schedule to improve measles protection in
high burden settings.
A study to investigate risk factors that could be incorporated into routine care to prevent severe infant infection in the first days of life.The studies are conducted at the Several KCCA facilities including Kawempe National Referral Hospital, Kisenyi health centre IV, Kawala and Komomboga and others by investigators from MU-JHU and SGUL through the EDCTP, Medical Research Council and Bill and Belinda Gates Foundation funding.

Session facilitators

Prof. Kirsty Le Doare
Dr. Eve Nakabembe
Dr. Robert Mboizi
Dr. Solomon Kamurari
Dr. Hannah Davis
Dr. Ouma Joseph
Dr. Geoff Kitson
Dr. Mary Kyohere
Dr. Alexander Amone
Dr. Gerald Businge
Dr. Lauren Hookham
Dr. Agnes Ssali
Victoria Nambasa
Anthony Ssebagereka
Esther Imede
Sarah Sturrock
Phiona Nalubega
Ritah Namugumya

Join Zoom Meeting:
https://us02web.zoom.us/j/88596947058?pwd=[REDACTED]
Meeting ID: 885 969

Annual BD Surveillance Stakeholders Meeting
2023-08-10 06:00 - 11:00

DXA Webinar
2023-11-09 13:00 - 15:00
MU-JHU Care Ltd. in association with the Uganda Medical Association Central Branch Executive Committee is pleased to invite you to a virtual CPD event.
Topic: Bone Mineral Density, Bone Quality & Body Composition: The Role of DXA Imaging
Date: 09 November 2023 (Thursday)
Time: 4:00PM-6:00PM (EAT)

Zoom Link:
https://us02web.zoom.us/j/86155658476?pwd=[REDACTED]
Coordinated by:
Dr. Mathias Lubega
CPD Chair-UMA Central Branch Executive Committee & Medical Officer-MUJHU Research Collaboration

HIP-CY Study Stakeholder Breakfast Meeting
2024-05-29 07:00 - 09:00 | MUJHU Research Collaboration, Mulago, Kampala, Uganda
